Thrombophilic conditions are due to a failure of antithrombotic mechanisms. Starting from this fact, the possibilities of influencing pharmacologically disturbances of biosynthesis and function of prostacyclin and plasminogen activator of the vessel wall as well as of plasmatic inhibitors of clotting factors were discussed. The results of experimental and clinical studies were reported.